Jiangsu Hengrui Medicine
600276.SS
#459
Rank
S$59.34 B
Marketcap
$9.30
Share price
-0.54%
Change (1 day)
5.54%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of September 2024 : S$8.48 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has S$8.48 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$S$7.46 B-1.06%
2021-12-31$S$7.54 B20.85%
2020-12-31$S$6.24 B29.75%
2019-12-31$S$4.81 B21.59%
2018-12-31$S$3.95 B20.76%
2017-12-31$S$3.27 B22.15%
2016-12-31$S$2.68 B18.7%
2015-12-31$S$2.26 B29.92%
2014-12-31$S$1.73 B24.87%
2013-12-31$S$1.39 B30.53%
2012-12-31$S$1.06 B18.32%
2011-12-31$S$0.90 B33.28%
2010-12-31$S$0.67 B23.58%
2009-12-31$S$0.54 B28.9%
2008-12-31$S$0.42 B30.12%
2007-12-31$S$0.32 B31.17%
2006-12-31$S$0.24 B8.87%
2005-12-31$S$0.22 B16.1%
2004-12-31$S$0.19 B6.09%
2003-12-31$S$0.18 B9.34%
2002-12-31$S$0.16 B0.15%
2001-12-31$S$0.16 B